A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part II: Secondary outcomes

Journal of Periodontology

Volumn 75, Issue 9, 2004, Pages 1188-1195

  Meyle, Jörg ^a   Gonzales, José R ^a   Bödeker, Rolf H ^a   Hoffmann, Thomas ^b   Richter, Steffen ^b   Heinz, Bernd ^c   Arjomand, Mehrdad ^c   Reich, Elmar ^d   Sculean, Anton ^d   Jepsen, Karin ^c   Jepsen, Søren ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c University of Homburg ^*

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Comparison studies; Furcation surgery; Furcation therapy; Guided tissue regeneration; Membranes, barrier; Proteins, enamel matrix; Statistical distribution

Indexed keywords

ENAMEL PROTEIN; POLITEF;

ADULT; AGED; ARTICLE; CEMENTUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENAMEL; FEMALE; GINGIVA BLEEDING; HEALING; HUMAN; MALE; MANDIBLE; MOLAR TOOTH; MULTICENTER STUDY; OSTEOLYSIS; OUTCOMES RESEARCH; PERIODONTAL DISEASE; PERIODONTICS; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; TOOTH PLAQUE;

ABSORBABLE IMPLANTS; ADULT; AGED; ALVEOLAR PROCESS; DENTAL ENAMEL PROTEINS; DENTAL PLAQUE INDEX; FEMALE; FOLLOW-UP STUDIES; FURCATION DEFECTS; GINGIVAL HEMORRHAGE; GINGIVAL RECESSION; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; MALE; MANDIBULAR DISEASES; MEMBRANES, ARTIFICIAL; MIDDLE AGED; MOLAR; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; TREATMENT OUTCOME;

EID: 4644350550     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.9.1188     Document Type: Article

References (36)

1. Lekovic V, Kenney EB, Kovacevic K, Carranza FA Jr. Evaluation of guided tissue regeneration in Class II furcation defects. A clinical re-entry study. J Periodontol 1989;60: 694-698.
2. Kenney EB, Lekovic V, Elbaz JJ, Kovacevic K, Carranza FA Jr, Takei HH. The use of a porous hydroxylapatite implant in periodontal defects. II. Treatment of Class II furcation lesions in lower molars. J Periodontol 1988;59: 67-72.
3. Gottlow J, Nyman S, Lindhe J, Karring T, Wennström J. New attachment formation in the human periodontium by guided tissue regeneration. Case reports. J Clin Periodontol 1986;13:604-616.
4. Caffesse RG, Smith BA, Duff B, Morrison EC, Merrill D, Becker W. Class II furcations treated by guided tissue regeneration in humans: Case reports. J Periodontol 1990; 61:510-514.
5. Gantes B, Martin M, Garrett S, Egelberg J. Treatment of periodontal furcation defects. (II). Bone regeneration in mandibular class II defects. J Clin Periodontol 1988;15: 232-239.
6. Andersson B, Bratthall G, Kullendorff B, Grondahl K, Rohlin M, Attstrom R. Treatment of furcation defects. Guided tissue regeneration versus coronally positioned flap in mandibular molars; a pilot study. J Clin Periodontol 1994;21:211-216.
7. Wallace SC, Gellin RG, Miller MC, Mishkin DJ. Guided tissue regeneration with and without decalcified freeze-dried bone in mandibular Class II furcation invasions. J Periodontol 1994;65:244-254.
8. Jepsen S, Eberhard J, Herrera D, Needleman I. A systematic review of guided tissue regeneration for periodontal furcation defects. What is the effect of guided tissue regeneration compared with surgical debridement in the treatment of furcation defects? J Clin Periodontol 2002;29:103-116.
9. Yukna RA. Clinical human comparison of expanded polytetrafluoroethylene barrier membrane and freeze-dried dura mater allografts for guided tissue regeneration of lost periodontal support. I. Mandibular molar Class II furcations. J Periodontol 1992;63:431-442.
10. Bouchard P, Ouhayoun JP, Nilveus RE. Expanded polytetrafluoroethylene membranes and connective tissue grafts support bone regeneration for closing mandibular Class II furcations. J Periodontol 1993;64:1193-1198.
11. Machtei EE, Grossi SG, Dunford R, Zambon JJ, Genco RJ. Long-term stability of Class II furcation defects treated with barrier membranes. J Periodontol 1996;67: 523-527.
12. Camelo MC, Nevins ML, Nevins M. Treatment of Class II furcations with autogenous bone grafts and e-PTFE membranes. Int J Periodontics Restorative Dent 2000;20: 233-243.
13. Garrett S, Polson AM, Stoller NH, et al. Comparison of a bioabsorbable GTR barrier to a non-absorbable barrier in treating human Class II furcation defects. A multicenter parallel design randomized single-blind trial. J Periodontol 1997;68:667-675.
14. Sanz M, Giovannoli JL. Focus on furcation defects: Guided tissue regeneration. Periodontol 2000 2000;22: 169-189.
15. Hammarstrom L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24:658-668.
16. Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24: 705-714.
17. Hammarstrom L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-677.
18. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:8-19.
19. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol 2002;29:317-325.
20. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001;72:25-34.
21. Okuda K, Momose M, Miyazaki A, et al. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000;71:1821-1828.
22. Cardaropoli G, Leonhardt AS. Enamel matrix proteins in the treatment of deep intrabony defects. J Periodontol 2002; 73:501-504.
23. Bratthall G, Lindberg P, Havemose-Poulsen A, et al. Comparison of ready-to-use EMDOGAIN-gel and EMDOGAIN in patients with chronic adult periodontitis. J Clin Periodontol 2001;28:923-929.
24. Pontoriero R, Wennstrom J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999;26:833-840.
25. Heden G. A case report study of 72 consecutive Emdogain-treated intrabony periodontal defects: Clinical and radiographic findings after 1 year. Int J Periodontics Restorative Dent 2000;20:127-139.
26. Sculean A, Reich E, Chiantella GC, Brecx M. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): A report of 32 cases. Int J Periodontics Restorative Dent 1999;19:157-163.
27. Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:433-440.
28. Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol 2002;73:401-408.
29. Jepsen S, Heinz B, Jepsen K, et al. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part 1: Study design and results for primary outcomes. J Periodontol 2004;75:1150-1160.
30. Hugoson A, Ravald N, Fornell J, Johard G, Teiwik A, Gottlow J. Treatment of Class II furcation involvements in humans with bioresorbable and nonresorbable guided tissue regeneration barriers. A randomized multi-center study. J Periodontol 1995;66:624-634.
31. Wang HL, O'Neal RB, Thomas CL, Shyr Y, MacNeil RL. Evaluation of an absorbable collagen membrane in treating Class II furcation defects. J Periodontol 1994;65:1029-1036.
32. Parashis A, Tsiklakis K. Clinical and radiographic findings following application of enamel matrix derivative in the treatment of intrabony defects. A series of case reports. J Clin Periodontol 2000;27:705-713.
33. Heden G, Wennstrom J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999;26:855-860.
34. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V. Comparison of treatments of infrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol 2000;27:603-610.
35. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001;28:397-403.
36. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.